Newsroom

LONDON--(BUSINESS WIRE)--  Re: Lloyds Bank Corporate Markets plc USD 32,000,000.00 MATURING: 28-Sep-2026 ISIN: XS2695405915 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Mar-2026 TO 29-Jun-2026 HAS BEEN FIXED AT 4.75 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Jun-2026 WILL AMOUNT TO: USD 2,403.54 PER USD 200,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Lloyds Bank Corporate Markets plc USD 30,000,000.00 MATURING: 29-Sep-2026 ISIN: XS2697682826 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Mar-2026 TO 29-Jun-2026 HAS BEEN FIXED AT 4.75 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Jun-2026 WILL AMOUNT TO: USD 2,403.54 PER USD 200,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: First Abu Dhabi Bank P.J.S.C. USD 22,000,000.00 MATURING: 28-Mar-2029 ISIN: XS2793708566 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Mar-2026 TO 29-Jun-2026 HAS BEEN FIXED AT 4.64 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Jun-2026 WILL AMOUNT TO: USD 2,343.99 PER USD 200,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--Omdia’s latest research shows that the global smartphone market is undergoing a structural shift as rising component costs and geopolitical uncertainty push leading manufacturers to move away from low-cost, high-volume strategies and prioritize premium, high-value portfolios. According to Omdia’s global smartphone forecast, total global smartphone shipments are forecast to contract by 12.2% year-on-year (YoY) in 2026, dropping to 1,093 million units. This represents a d...

BRUSSELS--(BUSINESS WIRE)--TITAN Group has earned its first Gold Medal in the 2026 EcoVadis sustainability assessment, ranking among the top 5% of companies assessed globally and within the top 2% of companies in the cement, lime and plaster industry.The recognition reflects TITAN's continued progress in integrating sustainability across its business and value chain, with strengthened performance in the areas of environment, labor and human rights, ethics, and sustainable procurement. The improv...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that the European Commission has approved MAVIRET® (glecaprevir/pibrentasvir), an oral pangenotypic direct-acting antiviral (DAA) therapy, for the treatment of acute HCV infection without cirrhosis or with compensated cirrhosis in adults and children aged 3 years and older...

LONDON--(BUSINESS WIRE)--  Australia and New Zealand Banking Group Issue of AUD 80,000,000.00 Floating Rate Notes due 21 June 2029 Series No 2127 Tranche 1 MTN ISSUE NAME. Our Ref. MR2466 ISIN Code. XS2847664583 INTEREST AMT PER DENOM. CURRENCY CODE. AUD DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 91 INTEREST RATE. 5.2166 PCT VALUE DATE. 21/09/2026 INTEREST PERIOD. 22/06/2026 TO 21/09/2026 AUD 500,000.00 IS AUD 6,502.88 POOL FACTOR. N/A...

LONDON--(BUSINESS WIRE)--  Australia and New Zealand Banking Group Issue of GBP 245,000,000.00 Floating Rate Notes due September 2026 Series No 2173 Tranche 1 MTN ISSUE NAME. Our Ref. MU4674 ISIN Code. XS3191438079 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 91 INTEREST RATE. 4.07669 PCT VALUE DATE. 29/06/2026 INTEREST PERIOD. 30/03/2026 TO 29/06/2026 GBP 100,000.00 IS GBP 1,016.38 POOL FACTOR. N/A...

LONDON--(BUSINESS WIRE)--  ASB BANK LIMITED Issue of USD 26,500,000.00 Senior Floating Rate Notes due June 2028 Series no. 6529 Tranche 1 MTN ISSUE NAME. Our Ref. MP7667 ISIN Code. XS2643237469 TOTAL INTEREST AMT. CURRENCY CODE. USD DAY BASIS. Actual/360 (A004) NUM OF DAYS. 91 INTEREST RATE. 4.83647 PCT VALUE DATE. 29/06/2026 INTEREST PERIOD. 30/03/2026 TO 29/06/2026 USD 323,976.32 POOL FACTOR. N/A...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Food Allergy Science Initiative (FASI) today announced that it has joined Vie Ventures as a strategic collaborator. FASI will join Vie Ventures’ growing network of Strategic Collaborators, bringing world-leading expertise in food allergy and translational science to a collaborative effort aimed at accelerating the development of novel therapies across immune-mediated diseases. As a Strategic Collaborator, FASI will contribute scientific and clinical expert...